236 related articles for article (PubMed ID: 21348818)
21. Expression and release of soluble HLA-E is an immunoregulatory feature of endothelial cell activation.
Coupel S; Moreau A; Hamidou M; Horejsi V; Soulillou JP; Charreau B
Blood; 2007 Apr; 109(7):2806-14. PubMed ID: 17179229
[TBL] [Abstract][Full Text] [Related]
22. Soluble HLA-G1 at the materno-foetal interface--a review.
Le Bouteiller P; Legrand-Abravanel F; Solier C
Placenta; 2003 Apr; 24 Suppl A():S10-5. PubMed ID: 12842408
[TBL] [Abstract][Full Text] [Related]
23. A human histocompatibility leukocyte antigen (HLA)-G-specific receptor expressed on all natural killer cells.
Rajagopalan S; Long EO
J Exp Med; 1999 Apr; 189(7):1093-100. PubMed ID: 10190900
[TBL] [Abstract][Full Text] [Related]
24. Molecular and immunologic aspects of the nonclassical HLA class I antigen HLA-G: evidence for an important role in the maternal tolerance of the fetal allograft.
Moreau P; Paul P; Rouas-Freiss N; Kirszenbaum M; Dausset J; Carosella ED
Am J Reprod Immunol; 1998 Sep; 40(3):136-44. PubMed ID: 9764357
[TBL] [Abstract][Full Text] [Related]
25. Special organization of the HLA-G protein on the cell surface.
Gonen-Gross T; Gazit R; Achdout H; Hanna J; Mizrahi S; Markel G; Horejsí V; Mandelboim O
Hum Immunol; 2003 Nov; 64(11):1011-6. PubMed ID: 14602229
[TBL] [Abstract][Full Text] [Related]
26. HLA-G expression in malignant melanoma.
Rebmann V; Wagner S; Grosse-Wilde H
Semin Cancer Biol; 2007 Dec; 17(6):422-9. PubMed ID: 17689098
[TBL] [Abstract][Full Text] [Related]
27. HLA-G in B-chronic lymphocytic leukaemia: clinical relevance and functional implications.
Rebmann V; Nückel H; Dührsen U; Grosse-Wilde H
Semin Cancer Biol; 2007 Dec; 17(6):430-5. PubMed ID: 17683947
[TBL] [Abstract][Full Text] [Related]
28. HLA Class I Antigen Processing Machinery Defects in Cancer Cells-Frequency, Functional Significance, and Clinical Relevance with Special Emphasis on Their Role in T Cell-Based Immunotherapy of Malignant Disease.
Seliger B; Ferrone S
Methods Mol Biol; 2020; 2055():325-350. PubMed ID: 31502159
[TBL] [Abstract][Full Text] [Related]
29. The potential role of HLA-G polymorphism in maternal tolerance to the developing fetus.
Agrawal S; Pandey MK
J Hematother Stem Cell Res; 2003 Dec; 12(6):749-56. PubMed ID: 14977483
[TBL] [Abstract][Full Text] [Related]
30. HLA-G1 co-expression boosts the HLA class I-mediated NK lysis inhibition.
Riteau B; Menier C; Khalil-Daher I; Martinozzi S; Pla M; Dausset J; Carosella ED; Rouas-Freiss N
Int Immunol; 2001 Feb; 13(2):193-201. PubMed ID: 11157852
[TBL] [Abstract][Full Text] [Related]
31. Human leukocyte antigen-G in cancer: are they clinically relevant?
Yan WH
Cancer Lett; 2011 Dec; 311(2):123-30. PubMed ID: 21843913
[TBL] [Abstract][Full Text] [Related]
32. Role of human leukocyte antigen-G in the induction of adaptive type 1 regulatory T cells.
Gregori S; Magnani CF; Roncarolo MG
Hum Immunol; 2009 Dec; 70(12):966-9. PubMed ID: 19664675
[TBL] [Abstract][Full Text] [Related]
33. A functional role of HLA-G expression in human gliomas: an alternative strategy of immune escape.
Wiendl H; Mitsdoerffer M; Hofmeister V; Wischhusen J; Bornemann A; Meyermann R; Weiss EH; Melms A; Weller M
J Immunol; 2002 May; 168(9):4772-80. PubMed ID: 11971028
[TBL] [Abstract][Full Text] [Related]
34. Structural studies on HLA-G: implications for ligand and receptor binding.
Clements CS; Kjer-Nielsen L; McCluskey J; Rossjohn J
Hum Immunol; 2007 Apr; 68(4):220-6. PubMed ID: 17400055
[TBL] [Abstract][Full Text] [Related]
35. Crystallization and preliminary X-ray analysis of the low-affinity complex between human leukocyte antigen-G (HLA-G) and leukocyte Ig-like receptor B2 (LILRB2).
Shiroishi M; Maenaka K
Protein Pept Lett; 2009; 16(4):447-9. PubMed ID: 19356145
[TBL] [Abstract][Full Text] [Related]
36. A homodimeric complex of HLA-G on normal trophoblast cells modulates antigen-presenting cells via LILRB1.
Apps R; Gardner L; Sharkey AM; Holmes N; Moffett A
Eur J Immunol; 2007 Jul; 37(7):1924-37. PubMed ID: 17549736
[TBL] [Abstract][Full Text] [Related]
37. Soluble HLA-G inhibits human dendritic cell-triggered allogeneic T-cell proliferation without altering dendritic differentiation and maturation processes.
Le Friec G; Laupèze B; Fardel O; Sebti Y; Pangault C; Guilloux V; Beauplet A; Fauchet R; Amiot L
Hum Immunol; 2003 Aug; 64(8):752-61. PubMed ID: 12878353
[TBL] [Abstract][Full Text] [Related]
38. HLA-G and immune tolerance in pregnancy.
Hunt JS; Petroff MG; McIntire RH; Ober C
FASEB J; 2005 May; 19(7):681-93. PubMed ID: 15857883
[TBL] [Abstract][Full Text] [Related]
39. HLA-G class I gene expression in normal and malignant hematopoietic cells.
Amiot L; Onno M; Drénou B; Monvoisin C; Fauchet R
Hum Immunol; 1998 Aug; 59(8):524-8. PubMed ID: 9712358
[TBL] [Abstract][Full Text] [Related]
40. HLA-G and NK receptor are expressed in psoriatic skin: a possible pathway for regulating infiltrating T cells?
Aractingi S; Briand N; Le Danff C; Viguier M; Bachelez H; Michel L; Dubertret L; Carosella ED
Am J Pathol; 2001 Jul; 159(1):71-7. PubMed ID: 11438456
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
